Dublin, Nov. 05, 2024 (GLOBE NEWSWIRE) — The “UAE Interventional Cardiology Devices Market, By Region, Competition, Forecast and Opportunities 2019-2029F” report has been added to ResearchAndMarkets.com’s offering.
The UAE Interventional Cardiology Devices Market was valued at USD 55.34 million in 2023, and is expected to reach USD 73.69 million by 2029, rising at a CAGR of 5.06%
The UAE interventional cardiology devices market represents a vital segment within the broader healthcare sector, driven by several key factors. And the rising facilities leads to the growth of cardiovascular devices market.
FibriCheck’s technology allows users to monitor their heart rhythm remotely through smartphone apps, enabling early detection of irregularities. Partnering with Pfizer and Altibbi enhances outreach efforts and underscores the importance of proactive AF screening in improving cardiovascular health across the Emirates. As a dynamic and rapidly evolving market, it encompasses a variety of devices crucial for diagnosing and treating cardiovascular diseases (CVDs), which remain a leading cause of mortality in the region.
Angioplasty stents, including bare-metal and drug-eluting variants, are pivotal in restoring blood flow to blocked arteries, thereby reducing the risk of heart attacks and improving patient outcomes. Their dominance is underscored by continuous advancements in stent design, materials, and coatings, aimed at enhancing efficacy and reducing complications like restenosis.
Also, Catheters play a critical role in guiding interventional procedures such as angioplasty and stent placement, ensuring precision and safety during operations. Structural heart devices, including transcatheter heart valves and closure devices, cater to a growing demand for minimally invasive treatments of congenital heart defects and valve disorders. Plaque modification devices and hemodynamic flow alteration devices further complement these advancements, offering innovative solutions to manage complex cardiovascular conditions.
The market’s growth is bolstered by factors such as rising incidences of lifestyle-related diseases, increasing healthcare expenditure, and government initiatives to expand healthcare infrastructure. Moreover, the UAE’s position as a hub for medical tourism further drives demand for cutting-edge interventional cardiology procedures and devices. With ongoing technological innovations and strategic investments, the UAE interventional cardiology devices market is poised for continued expansion, contributing significantly to improving cardiovascular care and patient outcomes across the Emirates.
Product Type Insights
Based on the Product Type, Angioplasty Stents have asserted dominance in the UAE Interventional Cardiology Devices Market. angioplasty stents are dominant in the field of cardiovascular interventions. Stents are crucial as they provide structural support to arteries following angioplasty, which involves opening narrowed or blocked blood vessels to improve blood flow. Their dominance stems from their essential role in treating coronary artery disease, a prevalent condition in the UAE and globally.
Stents help maintain vessel patency and reduce the risk of re-narrowing (restenosis) post-procedure, thereby improving long-term outcomes for patients. Advancements in stent technology, including drug-eluting stents that release medication to prevent restenosis, have significantly enhanced their efficacy and safety. This has solidified their position as a preferred choice in cardiovascular interventions. The increasing adoption of minimally invasive procedures and the growing prevalence of lifestyle-related diseases contribute to the sustained demand for angioplasty stents in the UAE and worldwide, making them a dominant category within the cardiovascular device market.
Regional Insights
Dubai stand out as dominated in the UAE’s interventional cardiology devices market for several compelling reasons. The city boasts a robust healthcare infrastructure that includes world-class hospitals, specialized cardiac centers, and advanced catheterization labs equipped with cutting-edge interventional technologies. These facilities attract top-tier medical professionals and specialists, making Dubai a preferred destination for complex cardiac procedures, including interventional cardiology treatments.
Dubai’s strategic geographical location and excellent connectivity serve as a gateway for medical tourism from neighboring countries and globally. The city’s reputation for quality healthcare services and state-of-the-art medical facilities draws a diverse patient population seeking advanced treatments, including minimally invasive interventional cardiology procedures. Dubai’s proactive healthcare policies and regulatory frameworks support innovation and investment in medical technologies.
The government’s initiatives to promote Dubai as a hub for medical excellence and innovation encourage the adoption of advanced interventional cardiology devices and procedures. This environment fosters competition among healthcare providers, driving continuous improvements in patient care and outcomes. The presence of international healthcare partnerships and collaborations enhances Dubai’s capabilities in offering the latest interventional cardiology technologies and techniques. These collaborations facilitate knowledge exchange, training programs, and access to innovative medical devices, further solidifying Dubai’s leadership in the interventional cardiology devices market within the UAE.
Dubai’s combination of advanced healthcare infrastructure, strategic location, supportive regulatory environment, and international collaborations positions it as a dominant force in the UAE’s interventional cardiology devices market, catering not only to local residents but also to a global clientele seeking state-of-the-art cardiac care.
Key Attributes:
| Report Attribute | Details |
| No. of Pages | 87 |
| Forecast Period | 2023 – 2029 |
| Estimated Market Value (USD) in 2023 | $55.34 Million |
| Forecasted Market Value (USD) by 2029 | $73.69 Million |
| Compound Annual Growth Rate | 5.0% |
| Regions Covered | United Arab Emirates |
Report Scope
Key Market Players
- Medtronic Meta FZ-LLC
- Boston Scientific Corporation
- Abbott Laboratories, S.A.
- Biotronik UAE
- Edwards LifeSciences UAE
- B. Braun Medical Gulf FZ-LLC
- Terumo Middle East FZE
- Cook Medical UAE
- Vasmed UAE
- Life Mate Medical Equipment Trading LLC
UAE Interventional Cardiology Devices Market, By Product Type:
- Angioplasty Balloons
- Angioplasty Stents
- Structural Heart Devices
- Catheters
- Plaque Modification Devices
- Hemodynamic Flow Alteration Devices
- Others
UAE Interventional Cardiology Devices Market, By End User:
- Hospitals & Clinics
- Ambulatory Surgery Centers
- Others
UAE Interventional Cardiology Devices Market, By Region:
- Abu Dhabi
- Dubai
- Sharjah
- Rest of UAE
For more information about this report visit https://www.researchandmarkets.com/r/9hkou3
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- UAE Interventional Cardiology Devices Market
